Plasma Brain-Derived Tau in Prognosis of Large Vessel Occlusion Ischemic Stroke
Ricardo Varela,Fernando Gonzalez-Ortiz,Alexandre Dias,Nicoló Luca Knuth,Joana Fonte,Beatriz Pinto,Idil Yuksekel,Vasco Abreu,Isabel Silva,Liliana Igreja,Joana Lopes,José Silva,Rafael Dias,João Pedro Filipe,Maria João Malaquias,Ana Moutinho,Denis Gabriel,Ana Aires,Rui Antunes,José Pedro Rocha,Rui Felgueiras,Ricardo Almendra,Pedro Castro,Henrik Zetterberg,Rui Magalhães,Thomas K. Karikari,Manuel Correia,Kaj Blennow,Luís F. Maia
DOI: https://doi.org/10.1161/strokeaha.123.046117
IF: 10.17
2024-07-26
Stroke
Abstract:Stroke, Ahead of Print. BACKGROUND:Large vessel occlusion acute ischemic stroke prognosis improved following the 2015 endovascular therapy (EVT) trials. Blood-based biomarkers may improve outcome prediction. We aimed to assess plasma brain-derived tau (BD-Tau) performance in predicting post-EVT large vessel occlusion acute ischemic stroke outcomes.METHODS:We included 2 temporally independent prospective cohorts of anterior circulation in patients with large vessel occlusion acute ischemic stroke who successfully recanalized post-EVT. We measured plasma BD-Tau, GFAP (glial-fibrillary-acidic-protein), NfL (neurofilament-light-chain), and total-Tau upon admission, immediately, 24 hours, and 72 hours post-EVT. Twenty-four-hour neuroimaging and 90-day functional outcomes were independently assessed using the Alberta Stroke Program Early Computed Tomography Score (good outcome: >7 or unchanged) and the modified Rankin Scale (favorable outcome <3 or unchanged), respectively. Based on the first cohort (derivation), we built a multivariable logistic regression model to predict a 90-day functional outcome. Model results were evaluated using the second cohort (evaluation).RESULTS:In the derivation cohort (n=78, mean age=72.9 years, 50% women), 62% of patients had a good 24-hour neuroimaging outcome, and 45% had a favorable 90-day functional outcome. GFAP admission-to-EVT rate-of-change was the best predictor for early neuroimaging outcome but not for 90-day functional outcome. At admission, BD-Tau levels presented the highest discriminative performance for 90-day functional outcomes (area under the curve, 0.76 [95% CI, 0.65–0.87];P<0.001). The model incorporating age, admission BD-Tau, and 24-hour Alberta Stroke Program Early Computed Tomography Score achieved excellent discrimination of 90-day functional outcome (area under the curve, 0.89 [95% CI, 0.82–0.97];P<0.001). The score's predictive performance was maintained in the evaluation cohort (n=66; area under the curve, 0.82 [95% CI, 0.71–0.92];P<0.001).CONCLUSIONS:Admission plasma BD-Tau accurately predicted 90-day functional outcomes in patients with large vessel occlusion acute ischemic stroke after successful EVT. The proposed model may predict functional outcomes using objective measures, minimizing human-related biases and serving as a simplified prognostic tool for AIS.
peripheral vascular disease,clinical neurology